Description
PE-22-28 10mg — TREK-1 potassium-channel research.
PE-22-28 10mg is a shortened spadin analogue studied for its interaction with the TREK-1 potassium channel. The seven-amino-acid peptide is used as a subject of experimental ion-channel research.
What the Research Shows
Djillani and colleagues compared PE-22-28 with spadin using cell-based electrophysiology and preclinical models. Their work examined channel inhibition, selectivity and modifications to the peptide. These findings concern experimental mechanisms and do not establish an antidepressant treatment for human use. See the Original PE-22-28 and TREK-1 study for the original context.
PE-22-28 10mg Product Details
- Product: PE-22-28 10mg
- Labelled amount: 10 mg per vial
- Research context: TREK-1 potassium-channel research
- Product code: PE2228-10
Batch-specific identity and analytical specifications should be checked against the matching supplier documentation. Published research describes the authors’ materials and methods; it is not a certificate of analysis for this product.
Related Research Resources
Explore the Purpose Labs research library for further background. Related catalogue entries include Semax 10mg and Selank 10mg. These are separate compounds with their own research profiles.
For research use only. Not for human consumption.




